购物车
全部删除
您的购物车当前为空
别名 达昔单抗, Zenapax, Ro 24-7375
Daclizumab (Zenapax)为人源化单抗,能特异性地抑制IL-2R-HA的α亚单位。Daclizumab (Zenapax)能通过与CD25的特异性结合而抑制IL-2和IL-2R-HA的结合。Daclizumab (Zenapax)研究多发性硬化症 。

为众多的药物研发团队赋能,
让新药发现更简单!
Daclizumab (Zenapax)为人源化单抗,能特异性地抑制IL-2R-HA的α亚单位。Daclizumab (Zenapax)能通过与CD25的特异性结合而抑制IL-2和IL-2R-HA的结合。Daclizumab (Zenapax)研究多发性硬化症 。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 997 | 现货 | |
| 5 mg | ¥ 2,890 | 现货 | |
| 10 mg | ¥ 4,990 | 现货 | |
| 25 mg | ¥ 7,790 | 现货 | |
| 50 mg | ¥ 10,500 | 现货 | |
| 100 mg | ¥ 14,200 | 现货 |
Daclizumab 相关产品
| 产品描述 | Daclizumab (Zenapax) is a humanized monoclonal antibody that specifically inhibits the alpha subunit of IL-2R-HA. Daclizumab (Zenapax) can inhibit the binding of IL-2 and IL-2R-HA through specific binding to CD25. Daclizumab (Zenapax) studies multiple sclerosis. |
| 别名 | 达昔单抗, Zenapax, Ro 24-7375 |
| 交叉反应 | Human |
| 验证活性 | Immobilized TARGET at 2 μg/mL (30 μL/well) can bind Anti-IL-2Ra / CD25 Reference Antibody (daclizumab) with the EC50 of 2.707 ng/mL. |
| 应用 | ELISA FACS Functional assay |
| 抗体种类 | Monoclonal |
| 宿主来源 | < 1.0 EU/mg |
| 偶联 | Unconjugated |
| Uniprot ID |
| 分子量 | 144.12 kDa |
| CAS No. | 152923-56-3 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容